Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn's disease.
Wang Z, Tian L, Jiang Y, Ning L, Zhu X, Chen X, Xuan B, Zhou Y, Ding J, Ma Y, Zhao Y, Huang X, Hu M, Fang JY, Shen N, Cao Z, Chen H, Wang X, Hong J.
Cell Metab. 2025 May 6;37(5):1089-1102.e7. doi: 10.1016/j.cmet.2025.01.007. Epub 2025 Feb 19.
Enterococci enhance Clostridioides difficile pathogenesis.
Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, Rangel PC, Di C, Green J, Bustin KA, Gaddy JA, Nicholson MR, Laut C, Kelly BJ, Matthews ML, Evans DR, Van Tyne D, Furth EE, Papin JA, Bushman FD, Erlichman J, Baldassano RN, Silverman MA, Dunny GM, Prentice BM, Skaar EP, Zackular JP.
Nature. 2022 Nov;611(7937):780-786. doi: 10.1038/s41586-022-05438-x. Epub 2022 Nov 16.
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, Mohsen A, Chen YA, Kawashima H, Natsume-Kitatani Y, Oka Y, Shimizu H, Furuta M, Tojima Y, Sawane K, Saika A, Kondo S, Yonejima Y, Takeyama H, Matsutani A, Mizuguchi K, Miyachi M, Kunisawa J.
Nat Commun. 2022 Aug 18;13(1):4477. doi: 10.1038/s41467-022-32015-7.
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.
Cherkaoui S, Turn CS, Yuan Y, Lu W, Yang L, McBride MJ, Eigenmann C, Allen GE, Panasenko OO, Zhang L, Vu A, Liu K, Li Y, Gandhi OH, Surrey LF, Kienast SD, Leidel SA, Wierer M, White E, Rabinowitz JD, Hogarty MD, Morscher RJ.
Nature. 2025 Oct;646(8085):707-715. doi: 10.1038/s41586-025-09564-0. Epub 2025 Sep 24.
M1 and M2 Macrophages: Oracles of Health and Disease.
Mills CD.
Crit Rev Immunol. 2012;32(6):463-88. doi: 10.1615/critrevimmunol.v32.i6.10.
LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages.
Wei Z, Oh J, Flavell RA, Crawford JM.
Nature. 2022 Sep;609(7926):348-353. doi: 10.1038/s41586-022-05111-3. Epub 2022 Aug 17.
Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
Luo Q, Liang W, Zhang Z, Zhu Z, Chen Z, Hu J, Yang K, Chi Q, Ding G.
Metabolism. 2022 Sep;134:155245. doi: 10.1016/j.metabol.2022.155245. Epub 2022 Jun 30.
Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription.
Peng V, Cao S, Trsan T, Bando JK, Avila-Pacheco J, Cleveland JL, Clish C, Xavier RJ, Colonna M.
Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2214900119. doi: 10.1073/pnas.2214900119. Epub 2022 Oct 24.
The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Martinelli D, Diodato D, Ponzi E, Monné M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C.
Orphanet J Rare Dis. 2015 Mar 11;10:29. doi: 10.1186/s13023-015-0242-9.
Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM, Rouleau G, Brice A, Nicholson G, Darios F, Loureiro JL, Zuchner S, Ottolenghi C, Mochel F, Stevanin G.
Brain. 2015 Aug;138(Pt 8):2191-205. doi: 10.1093/brain/awv143. Epub 2015 May 29.
